Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948.
Torabi P, Rivasi G, Hamrefors V, Ungar A, Sutton R, Brignole M, et al. Early and late-onset syncope: insight into mechanisms. Eur Heart J. 2022;43:2116–23.
Article PubMed PubMed Central Google Scholar
Sheldon R, Faris P, Tang A, Ayala-Paredes F, Guzman J, Marquez M, Morillo CA, Krahn AD, Kus T, Ritchie D, Safdar S, Maxey C, Raj SR, POST 4 investigators. Midodrine for the prevention of vasovagal syncope: a randomized clinical trial. Ann Intern Med. 2021;174(10):1349–56.
Sheldon R, Raj SR, Rose MS, Morillo CA, Krahn AD, Medina E, Talajic M, Kus T, Seifer CM, Lelonek M, Klingenheben T, Parkash R, Ritchie D, McRae M, POST 2 Investigators. Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2016;68(1):1–9.
Article CAS PubMed Google Scholar
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427–520.
Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, International study on syncope of uncertain etiology 3 (ISSUE-3) investigators, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third international study on syncope of uncertain etiology (ISSUE-3): a randomized trial. Circulation. 2012;125:2566–71.
Baron-Esquivias G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, Ruiz-Granell R, Lacunza-Ruiz J, et al. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study. J Am Coll Cardiol. 2017;70:1720–8.
Brignole M, Russo V, Arabia F, Oliveira M, Pedrote A, Aerts A, et al. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J. 2021;42:508–16.
Pachon MJC, Pachon MEI, Pachon MJC, Lobo TJ, Pachon MZ, Vargas RN, et al. A new treatment for atrial fibrillation based on spectral analysis to guide the catheter RF-ablation. Europace. 2004;6:590–601.
Pachon JC, Pachon EI, Cunha Pachon MZ, Lobo TJ, Pachon JC, Santillana TG. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace. 2011;13(9):1231–42.
Sun W, Zheng L, Qiao Y, Shi R, Hou B, Wu L, et al. Catheter ablation as a treatment for vasovagal syncope: long-term outcome of endocardial autonomic modification of the left atrium. J Am Heart Assoc. 2016;5: e003471.
Article PubMed PubMed Central Google Scholar
Rivarola EW, Hachul D, Wu T, Pisani C, Hardy C, Raimundi F, et al. Targets and end points in cardiac autonomic denervation procedures. Circ Arrhythm Electrophysiol. 2017;10: e004638.
Debruyne P, Rossenbacker T, Collienne C, Roosen J, Ector B, Janssens L, et al. Unifocal right-sided ablation treatment for neurally mediated syncope and functional sinus node dysfunction under computed tomographic guidance. Circ Arrhythm Electrophysiol. 2018;11: e006604.
Aksu T, Guler TE, Mutluer FO, Bozyel S, Golcuk SE, Yalin K. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study. J Interv Card Electrophysiol. 2019;54:177–88.
Hu F, Zheng L, Liang E, Ding L, Wu L, Chen G, et al. Right anterior ganglionated plexus: the primary target of cardioneuroablation? Heart Rhythm. 2019;16:1545–51.
Aksu T, Guler TE, Bozyel S, Yalin K, Gopinathannair R. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation. Europace. 2020;22:1320–7.
Calo L, Rebecchi M, Sette A, Sciarra L, Borelli A, Scara A, et al. Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective study. J Interv Card Electrophysiol. 2021;61:499–510.
Xu L, Zhao Y, Duan Y, Wang R, Hou J, Wang J, et al. Clinical efficacy of catheter ablation in the treatment of vasovagal syncope. J Clin Med. 2022;11(18):5371.
Article PubMed PubMed Central Google Scholar
Stec S, Wileczek A, Reichert A, Śledź J, Kosior J, Jagielski D, et al. Shared decision making and cardioneuroablation allow discontinuation of permanent pacing in patients with vagally mediated bradycardia. J Cardiovasc Dev Dis. 2023;10:392.
PubMed PubMed Central Google Scholar
Kulakowski P, Baran J, Sikorska A, Krynski T, Niedzwiedz M, Soszynska M, et al. Cardioneuroablation for reflex asystolic syncope - mid-term safety, efficacy and patient’s acceptance. Heart Rhythm 2023:S1547–527102972–7.
Tu B, Wu L, Hu F, Fan S, Liu S, Liu L, et al. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope. Heart Rhythm. 2022;19:562–9.
Santos Silva G, Fonseca P, Cardoso F, Almeida J, Ribeiro S, Oliveira M, et al. Cardioneuroablation for severe neurocardiogenic syncope. Rev Port Cardiol. 2023;42:821–9.
••Vandenberk B, Lei LY, Ballantyne B, Vickers D, Liang Z, Sheldon RS, et al. Cardioneuroablation for vasovagal syncope: a systematic review and meta-analysis. Heart Rhythm. 2022;19:1804–12. Vandenberg et al. provide a freedom from syncope estimate for cardioneuroablation, including subgroup analysis by method and target of ablation. The freedom from syncope was 91.9% in the whole study group. Right atrial cardioneuroablation was associated with a significant lower freedom from syncope (81.5%; 95% CI 51.9–94.7%; P <.0001) vs left atrial cardioneuroablation (94.0%; 95% CI 88.6–6.9%) and biatrial cardioneuroablation (92.7%; 95% CI 86.8–96.1%).
••Piotrowski R, Baran J, Sikorska A, Krynski T, Kulakowski P. Cardioneuroablation for reflex syncope: efficacy and effects on autonomic cardiac regulation-a prospective randomized trial. JACC Clin Electrophysiol. 2023;9:85–95. Piotrowski et al. present the results of the first randomized study documenting efficacy of cardioneuroablation in patients with cardioinhibitory type vasovagal syncope. The primary endpoint (syncope recurrence) occurred in 2 patients (8%) from the cardioneuroablation group versus 13 control patients (54%) (P = 0.0004).
Rivasi G, Torabi P, Secco G, Ungar A, Sutton R, Brignole M, et al. Age-related tilt test responses in patients with suspected reflex syncope. EP Europace. 2021;23:1100–5.
van Dijk JG, van Rossum IA, van Houwelingen M, Ghariq M, Saal DP, de Lange FJ, et al. Influence of age on magnitude and timing of vasodepression and cardioinhibition in tilt-induced vasovagal syncope. Clin Electrophysiol. 2022;8:997–1009.
Fucà G, Dinelli M, Suzzani P, Scarfò S, Tassinari F, Alboni P. The venous system is the main determinant of hypotension in patients with vasovagal syncope. Europace. 2006;8:839–45.
Van Dijk JG, Ghariq M, Kerkhof FI, Reijntjes R, Van Houwelingen MJ, Van Rossum IA, et al. Novel methods for quantification of vasodepression and cardioinhibition during tilt-induced vasovagal syncope. Circ Res. 2020;127:e126–38.
Brignole M, Aksu T, Calò L, Debruyne P, Deharo JC, Fanciulli A, et al. Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. Europace. 2023;25:euad033.
Article PubMed PubMed Central Google Scholar
Brignole M, Menozzi C, Del RA, Costa S, Gaggioli G, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace. 2000;2:66–76.
Article CAS PubMed Google Scholar
Janig W. Functional anatomy of the peripheral sympathetic and parasympathetic system. In: The Integrative action of the autonomic nervous system: neurobiology of homeostasis edited by J. W. Cambridge University Press 2006.
Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259:353–82.
Article CAS PubMed Google Scholar
Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289–98.
Article CAS PubMed Google Scholar
Ulphani JS, Arora R, Cain JH, Villuendas R, Shen S, Gordon D, et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol. 2007;293:H1629–35.
Article CAS PubMed Google Scholar
Randall WC, Ardell JL, O’Toole MF, Wurster RD. Differential autonomic control of SAN and AVN regions of the canine heart: structure and function. Prog Clin Biol Res. 1988;275:15–31.
Billman GE, Hoskins RS, Randall DC, Randall WC, Hamlin RL, Lin YC. Selective vagal postganglionic innervation of the sinoatrial and atrioventricular nodes in the non-human primate. J Auton Nerv Syst. 1989;26:27–36.
Article CAS PubMed Google Scholar
Aksu T, Gopinathannair R, Gupta D, Pauza DH. Intrinsic cardiac autonomic nervous system: what do clinical electrophysiologists need to know about the “heart brain”? J Cardiovasc Electrophysiol. 2021;32:1737–47.
•Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. “Cardioneuroablation”–new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005;7(1):1–13. Pachon et al. firstly apply cardioneuroablation technique in patients with vagally mediated bradyarrhythmias.
Aksu T, Golcuk E, Yalin K, Guler TE, Erden I. Simplified cardioneuroablation in the treatment of reflex syncope, functional AV block, and sinus node dysfunction. Pacing Clin Electrophysiol. 2016;39(1):42–53.
留言 (0)